Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit
30-Jul-2009 -
Watson Pharmaceuticals, Inc. announced a license agreement with GeneraMedix, Inc. for the exclusive US marketing rights to a generic version of Ferrlecit (sodium ferric gluconate complex in sucrose injection), a drug indicated for the treatment of iron deficiency anemia in hemodialysis patients ...
iron deficiency
license agreements
Sanofi-aventis
+1